17 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
standards and other laws and regulations, such as those related to environmental health and safety matters.
To meet our projected needs for clinical
6-K
EX-99.3
OBSVF
ObsEva SA
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, applicable
6-K/A
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
health and safety, product quality and safety and employment and labor matters, applicable to the Company, except in each case as would
6-K
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, applicable to the Company, except in each
6-K
EX-1.1
ad0v2l8zxxf8ffngp1
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
uox3ifdw lx
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.1
ywqcz0
23 Mar 20
ObsEva Provides Update Related to COVID-19 Pandemic
4:00pm
6-K
EX-99.1
a4rjun 4wp8bucd8id
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-1.1
v4n5e5ura8wawwnj
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
20-F
d4ogkj
21 Apr 17
Annual report (foreign)
12:00am
F-1
ff2ndbx11k k9mu0
30 Dec 16
Registration statement (foreign)
12:00am
DRS
70pcmky7ocy
14 Oct 16
Draft registration statement
12:00am
- Prev
- 1
- Next